7 completed, 1 unknown. 6 Phase 2, 3 Phase 3, 2 Phase 1, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 6 | Completed 5, Unknown 1 |
| Phase 3 | 3 | Completed 2, Unknown 1 |
| Phase 1 | 2 | Completed 2 |
| Phase 4 | 1 | Completed 1 |
Follow Axcan Pharma: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Enzyme Suppletion in Exocrine Pancreatic Dysfunction Panzytrat 25.000 FIP-E units of Lipase - Chronic Pancreatitis, Exocrine Pancreatic Insufficiency | Phase 4 | Completed | Foundation for Liver Research | 10 | 2011-10-01 | 2015-03-11 |
| Safety Study Using Photodynamic Therapy Light Therapy for Patients With Chest Wall Progression of Breast Cancer and Satellite Metastases of Melanoma CLIPT patch - Breast Cancer, Skin Cancer | Phase 1 | Completed | Tufts Medical Center | 48 | 2009-01-01 | 2011-09-26 |
| An Open-Label Study to Evaluate the Intraduodenal Delivery of Enzymes From Administration of VIOKASE16 in Exocrine Pancreatic Insufficiency (EPI) VIOKASE 16 - Exocrine Pancreatic Insufficiency | Phase 2 | Completed | Axcan Pharma | 22 | 2008-03-01 | 2010-02-11 |
| A Study to Evaluate the Effect of a Medicine on Gastric Functions in Healthy Volunteers. Itopride - Healthy Volunteers | Phase 2 / Phase 3 | Completed | Mayo Clinic | 45 | 2005-11-01 | 2011-03-23 |
| Pilot Study of Ursodesoxycholic Acid in Non-Alcoholic Steatohepatitis Ursodesoxycholic acid - Serum Levels of ALAT Transaminases, Serum Markers for Fibrosis and Hepatic Inflammation | Phase 2 | Completed | Axcan Pharma | 98 | 2005-10-01 | 2009-02-03 |
| Sequential Whole Bladder Photodynamic Therapy (WBPDT) in the Management of Superficial Bladder Cancer Whole bladder laser light treatment as an alternative to radical cystectomy, Photofrin - Superficial Bladder Cancer | Phase 1 / Phase 2 | Completed | North Florida/South Georgia Veterans Health System | 22 | 2005-02-01 | 2012-10-26 |
| Ursodeoxycholic Acid in the Treatment of Duodenal Adenomas in Familial Adenomatous Polyposis (FAP) Patients Ursodeoxycholic acid, Placebo - Adenomatous Polyposis Coli, Familial | Phase 2 / Phase 3 | Unknown | Assistance Publique - Hôpitaux de Paris | 90 | 2004-10-01 | 2009-07-29 |
| Study of Combivir for Patients With Primary Biliary Cirrhosis Combination antiviral therapy, Placebo - Primary Biliary Cirrhosis | Phase 2 / Phase 3 | Completed | University of Alberta | 59 | 2004-01-01 | 2007-11-01 |
Exocrine Pancreatic Insufficiency (2) · Adenoma (1) · Adenomatous Polyposis Coli (1) · Breast Neoplasms (1) · Liver Cirrhosis, Biliary (1) · Melanoma (1) · Neoplasms (1) · Non-Muscle Invasive Bladder Neoplasms (1) · Pancreatitis, Chronic (1) · Photosensitivity Disorders (1) · Skin Neoplasms (1) · Urinary Bladder Neoplasms (1)
Dihematoporphyrin Ether (1) · Pancrelipase (1) · Ursodeoxycholic Acid (1) · itopride (1) · lamivudine, zidovudine drug combination (1)
United States (5) · France (2) · Canada (1) · Netherlands (1) · United Kingdom (1)
Andrew L Mason, MBBS MRCPI (1) · Bruce Bacon, MD (1) · Catherine Vincent, MD FRCPC (1) · James Neuberger, MD FRCP (1) · Keith Lindor, MD (1) · Marco Bruno, MD, PhD (1) · Nicholas J. Talley, M.D., Ph.D. (1) · Phillip P. Toskes, M.D. (1) · Roger Graham, MD (1) · Unyime O Nseyo, M.D. (1) · Vlad Ratziu, M.D., Ph.D. (1) · Yann RA Parc, M.D., Ph.D. (1)